Chicken Anaemia Virus Putative proteins (VP1) antibody and antigen (recombinant protein)

Diagnostic anti-Chicken Anaemia Virus Putative proteins (VP1) antibodies pairs and antigen for animal health (animal Avian/Bird/Poultry infectious disease Chicken infectious anemia) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Avian/Bird/Poultry disease testing products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-VT-P183-Tg001-Ag01 Recombinant Chicken Anaemia Virus Putative proteins (VP1) protein $3090.00
GMP-VT-P183-Tg001-Ab01 Anti-Chicken Anaemia Virus Putative proteins (VP1) mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P183-Tg001-Ab02 Anti-Chicken Anaemia Virus Putative proteins (VP1) mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P183-Tg001-Ab03 Anti-Chicken Anaemia Virus Putative proteins (VP1) human monoclonal antibody (mAb) $3090.00
GMP-VT-P183-Tg001-Ab04 Anti-Chicken Anaemia Virus Putative proteins (VP1) human monoclonal antibody (mAb) $3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-VT-P183-Tg001-Ag01
Product Name Recombinant Chicken Anaemia Virus Putative proteins (VP1) protein
Pathogen Chicken Anaemia Virus
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Chicken Anaemia Virus Putative proteins (VP1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Chicken Anaemia Virus level test of animal Avian/Bird/Poultry infectious disease with Chicken infectious anemia.
Tag His
Product description Recombinant Chicken Anaemia Virus Putative proteins (VP1) proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P183-Tg001-Ab01,GMP-VT-P183-Tg001-Ab02
Pathogen Chicken Anaemia Virus
Product Name Anti-Chicken Anaemia Virus Putative proteins (VP1) mouse monoclonal antibody (mAb)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Chicken Anaemia Virus Putative proteins (VP1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Chicken Anaemia Virus antibodies in Chicken Anaemia Virus level test of animal Avian/Bird/Poultry infectious disease with Chicken infectious anemia.
Product description Anti-Chicken Anaemia Virus Putative proteins (VP1) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Chicken Anaemia Virus antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P183-Tg001-Ab03,GMP-VT-P183-Tg001-Ab04
Pathogen Chicken Anaemia Virus
Product Name Anti-Chicken Anaemia Virus Putative proteins (VP1) human monoclonal antibody (mAb)
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Recombinant Chicken Anaemia Virus Putative proteins (VP1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Chicken Anaemia Virus antibodies in Chicken Anaemia Virus level test of animal Avian/Bird/Poultry infectious disease with Chicken infectious anemia.
Product description Anti-Chicken Anaemia Virus Putative proteins (VP1) mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Pathogen Information


    Chicken Anaemia Virus (CAV) is a circular, single-stranded DNA virus belonging to the family Circoviridae. The virus is characterized by a small, non-enveloped virion, with a genome size of approximately 2.3 kilobases. There are two major ORFs on the CAV genome, including the rep gene and the cap gene. The former encodes a replication-associated protein, while the latter encodes a viral capsid protein known as VP1. VP1 is highly immunogenic and plays a critical role in the virulence of the virus.

    CAV is primarily known for its ability to infect chickens, causing a severe disease known as Chicken Anaemia Disease (CAD). Birds infected with CAV typically exhibit clinical symptoms such as anemia, lymphoid depletion, and immunosuppression. The disease can be further classified into three different forms based on the age of the bird at the time of infection. These forms include subclinical infections, clinical infections, and late-onset infections.

    Subclinical infections are common in young birds less than two weeks old, which display no clinical signs of disease. However, these birds may develop persistent infections that can lead to problems later in life. Clinical infections, on the other hand, occur in older birds between two and five weeks old. These birds exhibit classical symptoms of anemia, lymphoid depletion, and immunosuppression, often leading to morbidity and mortality. Lastly, late-onset infections occur in birds over five weeks old, exhibiting symptoms similar to those seen in clinical infections.

    Although CAV primarily infects chickens, the virus has also been reported in other avian species such as turkeys, ducks, and pigeons. However, these species do not usually develop clinical symptoms of disease but can serve as a reservoir for the virus.

    Diagnosis of CAV can be accomplished using a variety of methods, including ELISA, PCR, and nucleic acid hybridization assays. The most commonly targeted gene in CAV diagnostics is the VP1 gene, which encodes the viral capsid protein. Other genes, such as the rep gene, may also serve as targets for diagnostic assays.

    Vaccination is an effective means of controlling CAV infections in chickens. A number of different vaccines are available commercially, including attenuated and inactivated virus vaccines, as well as recombinant VP1 protein-based vaccines. Vaccination has been shown to be highly effective in reducing the incidence of CAD in chickens.

    In summary, CAV is a small, circular DNA virus that primarily infects chickens, causing a severe disease known as Chicken Anaemia Disease. Although CAV has been reported in other avian species, these species do not typically develop clinical symptoms of disease. Diagnosis of CAV can be accomplished using a range of diagnostic methods that target VP1 and other genes. Vaccination is an effective means of controlling CAV infections in chickens and reducing the incidence of CAD.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.